+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A new diagnostic test for Gaucher disease suitable for population screening



A new diagnostic test for Gaucher disease suitable for population screening



Pcr Methods and Applications 4(1): 1-5



A new test for the diagnosis of Gaucher disease is described. The test is designed to screen large numbers of clinical specimens from high-risk populations. It consists of duplex PCR amplification of genomic DNA followed by hybridization to alkaline phosphatase-conjugated allele-specific oligonucleotide probes (ASOs). High melting temperature PCR primers were used to increase specificity and eliminate the need for a separate annealing step. All hybridization and washing steps were performed at one temperature. Chemiluminescent detection of signals is fast, and results are easily interpreted directly from x-ray films. Currently, the test is being used in our laboratories to screen Ashkenazi Jewish populations in whom Gaucher disease is common.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045079948

Download citation: RISBibTeXText

PMID: 9018309


Related references

Is the captopril test suitable as a screening test for renovascular hypertension in a general hypertensive population?. International Journal of Angiology 5(4): 192-195, 1996

Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurology 71(4): 421-428, 2014

Gaucher's disease: genetic counselling and population screening. Bailliere's Clinical Haematology 10(4): 779-792, 1998

Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. Plos One 8(11): E79732, 2014

Three Gaucher-disease-producing mutations in a patient with Gaucher disease: mechanism and diagnostic implications. Acta Haematologica 104(2-3): 103-105, 2001

Trial therapy with proton pump inhibitors is not a suitable test for gastroesophageal reflux disease; a meta-analysis of the diagnostic test characteristics. Nederlands Tijdschrift Voor Geneeskunde 148(39): 1924-1928, 2004

Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. Bmj 335(7632): 1244-1247, 2007

Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population. Israel Medical Association Journal 8(5): 347-350, 2006

55-base pair deletion in certain patients with Gaucher disease complicates screening for common Gaucher alleles. American Journal of Medical Genetics 66(3): 316-319, 1996

Large scale screening for Gaucher's disease in Israel--a position paper by the National Gaucher Committee of the Ministry of Health. Harefuah 133(3-4): 107-108, 1997

Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proceedings of the National Academy of Sciences of the United States of America 88(23): 10544-7, 1991

Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY. Archives of Internal Medicine 158(7): 777-781, 1998

Successful screening for Gaucher disease in a high-prevalence population in tabuleiro do Norte (northeastern Brazil): a cross-sectional study. Jimd Reports 1: 73-78, 2011

alpha-Hemoglobin stabilizing protein is not a suitable marker for a screening test for variant Creutzfeldt-Jakob disease. Transfusion 48(8): 1616-1626, 2008

Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Molecular Genetics and Metabolism 122(3): 122-129, 2017